Fig. 8: Clinical prognostic potential of the MACC1-AS1/STK33 signaling axis in pancreatic cancer patients. | Cell Death Discovery

Fig. 8: Clinical prognostic potential of the MACC1-AS1/STK33 signaling axis in pancreatic cancer patients.

From: LncRNA MACC1-AS1 induces gemcitabine resistance in pancreatic cancer cells through suppressing ferroptosis

Fig. 8

A, B The OS, PFS and DFS of MACC1-AS1, MACC1-AS1 + STK33 were analyzed from TCGA PADC patients respectively. C The combination of MACC1-AS1 and STK33, MACC1-AS1, STK33 were used to establish the DCA module and analyzed 1 year OS time for PDAC patients.

Back to article page